C4BPA and Alzheimer disease: For instance, levels of two Aβ-binding proteins, including alpha-1-antichymotrypsin (AACT), were increased and the level of C4b-binding protein alpha chain (C4BPα) was decreased in plasma exosomes in a case of AD; these proteins were therefore identified as potential exosomal biomarker candidates for AD diagnosis [85].